Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antalgic Treatment of Painful Bone Metastases by US-guided High Intensity Focused Ultrasound (HIFU).

NCT01765907 is registered in ClinicalTrials.gov with Theraclion as lead sponsor.

NCT NCT01765907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01765907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antalgic Treatment of Painful Bone Metastases by US-guided High Intensity Focused Ultrasound (HIFU).
Lead sponsor
Theraclion
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2012
Completion date
March 31, 2014
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastasis